KLRG1 and neoplasm: Taken together, this analysis shows a mixed phenotype, as potentially tumor-induced immunosuppressive molecule such as CD73 is upregulated in peripheral T cells, whereas others, such as TIGIT and KLRG1, are reduced in NSCLC BM patients.